Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
May-2014 Volume 33 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2014 Volume 33 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Plexin-A1 is required for Toll-like receptor‑mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy

  • Authors:
    • Takuji Ito
    • Kenji Yoshida
    • Takayuki Negishi
    • Masayasu Miyajima
    • Hyota Takamatsu
    • Hitoshi Kikutani
    • Atsushi Kumanogoh
    • Kazunori Yukawa
  • View Affiliations / Copyright

    Affiliations: Department of Physiology, Faculty of Pharmacy, Meijo University, Nagoya 468-8503, Japan, Laboratory Animal Center, Wakayama Medical University, Wakayama 641-8509, Japan, Department of Immunopathology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan, Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
    Copyright: © Ito et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 1122-1130
    |
    Published online on: March 7, 2014
       https://doi.org/10.3892/ijmm.2014.1690
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Recent investigations have suggested that semaphorins, which are known repulsive axon guidance molecules, may play a crucial role in maintaining brain homeostasis by regulating microglial activity. Sema3A, secreted in higher amounts from injured neurons, is considered to suppress excessive inflammatory responses by inducing microglial apoptosis through its binding to Plexin-A1 receptors on activated microglia. To clarify the in vivo role of Plexin-A1-mediated signaling in lipopolysaccharide (LPS)-induced injury in mouse brain, we examined the neuroinflammatory changes initiated by LPS administration to the cerebral ventricles of wild-type (WT) and Plexin-A1-deficient (-/-) mice. WT mice administered LPS exhibited a significantly higher expression of COX-2, iNOS, IL-1β and TNF-α in the hippocampus, and a significantly greater ventricular enlargement and intracerebral infiltration of leukocytes, as compared with the saline-treated group. By contrast, Plexin-A1-/- mice administered LPS did not exhibit a significantly increased expression of COX-2, iNOS, IL-1β or TNF-α in the hippocampus as compared with the saline‑treated group. Plexin-A1-/- mice administered LPS did not show significant increases in ventricle size or infiltration of leukocytes into the brain, as compared with the saline-treated group. In WT, but not in the Plexin-A1-/- primary microglia treated with LPS, Sema3A induced significantly more nitric oxide production than in the immunoglobulin G control. These results revealed the crucial role of the Sema3A-Plexin-A1 interaction in the Toll-like receptor 4-mediated signaling of the LPS-induced activation of microglia. Thus, results of the present study revealed the essential role of Plexin-A1 in the development of LPS-induced neuroinflammation in mice, suggesting the possible application of microglial control of the semaphorin-plexin signaling system to the treatment of LPS-induced encephalopathy and other psychiatric diseases associated with neuroinflammation.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Ransohoff RM and Perry VH: Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol. 27:119–145. 2009. View Article : Google Scholar : PubMed/NCBI

2 

Heppner FL, Greter M, Marino D, et al: Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med. 11:146–152. 2005. View Article : Google Scholar : PubMed/NCBI

3 

Jack C, Ruffini F, Bar-Or A and Antel JP: Microglia and multiple sclerosis. J Neurosci Res. 81:363–373. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Ponomarev ED, Shriver LP and Dittel BN: CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J Immunol. 176:1402–1410. 2006. View Article : Google Scholar

5 

Lehnardt S, Lachance C, Patrizi S, et al: The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci. 22:2478–2486. 2002.PubMed/NCBI

6 

Lehnardt S, Massillon L, Follett P, et al: Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA. 100:8514–8519. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Heppner FL, Greter M, Marino D, et al: Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med. 11:146–152. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Tessier-Lavigne M and Goodman SC: The molecular biology of axon guidance. Science. 274:1123–1133. 1996. View Article : Google Scholar : PubMed/NCBI

9 

Pasterkamp RJ and Kolodkin AL: Semaphorin junction: making tracks toward neural connectivity. Curr Opin Neurobiol. 13:79–89. 2003. View Article : Google Scholar : PubMed/NCBI

10 

Sekido Y, Bader S, Latif F, et al: Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci USA. 93:4120–4125. 1996. View Article : Google Scholar : PubMed/NCBI

11 

Gu C, Rodriguez ER, Reimert DV, et al: Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell. 5:45–57. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Toyofuku T, Zhang H, Kumanogoh A, et al: Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat Cell Biol. 6:1204–1211. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Kumanogoh A, Watanabe C, Lee I, et al: Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity. 13:621–631. 2000. View Article : Google Scholar : PubMed/NCBI

14 

Shi W, Kumanogoh A, Watanabe C, et al: The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity. 13:633–642. 2000. View Article : Google Scholar : PubMed/NCBI

15 

Kumanogoh A, Marukawa S, Suzuki K, et al: Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature. 419:629–633. 2002. View Article : Google Scholar : PubMed/NCBI

16 

Kumanogoh A, Shikina T, Suzuki K, et al: Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice. Immunity. 22:305–316. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Kikutani H and Kumanogoh A: Semaphorins in interactions between T cells and antigen-presenting cells. Nat Rev Immunol. 3:159–167. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Elhabazi A, Marie-Cardine A, Chabbert-de Ponnat I, Bensussan A and Boumsell L: Structure and function of the immune semaphorin CD100/SEMA4D. Crit Rev Immunol. 23:65–81. 2003. View Article : Google Scholar : PubMed/NCBI

19 

Tamagnone L and Comoglio PM: Signalling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol. 10:377–383. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Granziero L, Circosta P, Scielzo C, et al: CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes. Blood. 101:1962–1969. 2003.PubMed/NCBI

21 

Walzer T, Galibert L, Comeau MR and De Smedt T: Plexin C1 engagement on mouse dendritic cells by viral semaphorin A39R induces actin cytoskeleton rearrangement and inhibits integrin-mediated adhesion and chemokine-induced migration. J Immunol. 174:51–59. 2005. View Article : Google Scholar

22 

Takahashi T, Fournier A, Nakamura F, et al: Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell. 99:59–69. 1999. View Article : Google Scholar : PubMed/NCBI

23 

Toyofuku T, Zhang H, Kumanogoh A, et al: Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev. 18:435–447. 2004. View Article : Google Scholar

24 

Wong AW, Brickey WJ, Taxman DJ, et al: CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions. Nat Immunol. 4:891–898. 2003. View Article : Google Scholar : PubMed/NCBI

25 

Shirvan A, Ziv I, Fleminger G, et al: Semaphorins as mediators of neuronal apoptosis. J Neurochem. 73:961–971. 1999. View Article : Google Scholar : PubMed/NCBI

26 

Fujita H, Zhang B, Sato K, Tanaka J and Sakanaka M: Expressions of neuropilin-1, neuropilin-2 and semaphorin 3A mRNA in the rat brain after middle cerebral artery occlusion. Brain Res. 914:1–14. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Pasterkamp RJ and Verhaagen J: Emerging roles for semaphorins in neural regeneration. Brain Res Brain Res Rev. 35:36–54. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Majed HH, Chandran S, Niclou SP, et al: A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. J Neurosci. 26:1730–1738. 2006. View Article : Google Scholar : PubMed/NCBI

29 

Takegahara N, Takamatsu H, Toyofuku T, et al: Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat Cell Biol. 8:615–622. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Zhou H, Lapointe BM, Clark SR, Zbytnuik L and Kubes P: A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J Immunol. 177:8103–8110. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Buttni M, Limonta S and Boddeke HW: Peripheral administration of lipopolysaccharide induces activation of microglial cells in rat brain. Neurochem Int. 29:25–35. 1996.PubMed/NCBI

32 

Grin’kina NM, Karnabi EE, Damania D, Wadgaonkar S, Muslimov IA and Wadgaonkar R: Sphingosine kinase 1 deficiency exacerbates LPS-induced neuroinflammation. PLoS One. 7:e364752012.PubMed/NCBI

33 

Banks WA and Erickson MA: The blood-brain barrier and immune function and dysfunction. Neurobiol Dis. 37:26–32. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Shaftel SS, Griffin WS and O’Banion MK: The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation. 5:72008. View Article : Google Scholar : PubMed/NCBI

35 

Wen H, Lei Y, Eun SY and Ting JP: Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor- and sepsis-induced cytokine storm. J Exp Med. 207:2943–2957. 2010. View Article : Google Scholar : PubMed/NCBI

36 

Durrenberger PF, Facer P, Gray RA, et al: Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury. J Peripher Nerv Syst. 9:15–25. 2004. View Article : Google Scholar : PubMed/NCBI

37 

Lehnardt S: Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia. 58:253–263. 2010.PubMed/NCBI

38 

Shin WH, Lee DY, Park KW, et al: Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia. 46:142–152. 2004. View Article : Google Scholar : PubMed/NCBI

39 

Lee J, Hur J, Lee P, et al: Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells. Initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11. J Biol Chem. 276:32956–32965. 2001. View Article : Google Scholar

40 

Yang MS, Ji KA, Jeon SB, et al: Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: implications for death of activated microglia. J Immunol. 177:1323–1329. 2006. View Article : Google Scholar : PubMed/NCBI

41 

Choi SH, Aid S, Choi U and Bosetti F: Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain. Pharmacogenomics J. 10:448–457. 2010. View Article : Google Scholar : PubMed/NCBI

42 

Burguillos MA, Deierborg T, Kavanagh E, et al: Caspase signalling controls microglia activation and neurotoxicity. Nature. 472:319–324. 2011. View Article : Google Scholar : PubMed/NCBI

43 

Okuno T, Nakatsuji Y, Moriya M, et al: Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 184:1499–1506. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ito T, Yoshida K, Negishi T, Miyajima M, Takamatsu H, Kikutani H, Kumanogoh A and Yukawa K: Plexin-A1 is required for Toll-like receptor‑mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy. Int J Mol Med 33: 1122-1130, 2014.
APA
Ito, T., Yoshida, K., Negishi, T., Miyajima, M., Takamatsu, H., Kikutani, H. ... Yukawa, K. (2014). Plexin-A1 is required for Toll-like receptor‑mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy. International Journal of Molecular Medicine, 33, 1122-1130. https://doi.org/10.3892/ijmm.2014.1690
MLA
Ito, T., Yoshida, K., Negishi, T., Miyajima, M., Takamatsu, H., Kikutani, H., Kumanogoh, A., Yukawa, K."Plexin-A1 is required for Toll-like receptor‑mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy". International Journal of Molecular Medicine 33.5 (2014): 1122-1130.
Chicago
Ito, T., Yoshida, K., Negishi, T., Miyajima, M., Takamatsu, H., Kikutani, H., Kumanogoh, A., Yukawa, K."Plexin-A1 is required for Toll-like receptor‑mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy". International Journal of Molecular Medicine 33, no. 5 (2014): 1122-1130. https://doi.org/10.3892/ijmm.2014.1690
Copy and paste a formatted citation
x
Spandidos Publications style
Ito T, Yoshida K, Negishi T, Miyajima M, Takamatsu H, Kikutani H, Kumanogoh A and Yukawa K: Plexin-A1 is required for Toll-like receptor‑mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy. Int J Mol Med 33: 1122-1130, 2014.
APA
Ito, T., Yoshida, K., Negishi, T., Miyajima, M., Takamatsu, H., Kikutani, H. ... Yukawa, K. (2014). Plexin-A1 is required for Toll-like receptor‑mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy. International Journal of Molecular Medicine, 33, 1122-1130. https://doi.org/10.3892/ijmm.2014.1690
MLA
Ito, T., Yoshida, K., Negishi, T., Miyajima, M., Takamatsu, H., Kikutani, H., Kumanogoh, A., Yukawa, K."Plexin-A1 is required for Toll-like receptor‑mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy". International Journal of Molecular Medicine 33.5 (2014): 1122-1130.
Chicago
Ito, T., Yoshida, K., Negishi, T., Miyajima, M., Takamatsu, H., Kikutani, H., Kumanogoh, A., Yukawa, K."Plexin-A1 is required for Toll-like receptor‑mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy". International Journal of Molecular Medicine 33, no. 5 (2014): 1122-1130. https://doi.org/10.3892/ijmm.2014.1690
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team